Glenmark has received the Food and Drug Administration’s clearance for olopatadine hydrochloride ophthalmic solution, 0.2% ...

The FDA has determined it to be bioequivalent to Pataday Once Daily Relief Ophthalmic Solution, 0.2% (OTC), developed by Alcon Laboratories Inc. Olopatadine Hydrochloride Ophthalmic Solution USP ...

Glenmark Pharmaceuticals rose 1.95% to Rs 1,506.95 after its US subsidiary, Glenmark Pharmaceuticals Inc., USA, received approval from the US Food & Drug Administration (USFDA) for its Olopatadine ...

Glenmark Pharma's stock rose after it said Glenmark Pharmaceuticals Inc., USA, has received final approval from the USFDA for ...